Results 31 to 40 of about 67,859 (248)

Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada

Canadian Medical Association Journal, 2022
Background: The evolving proportion of the population considered immunologically naive versus primed for more efficient immune memory response to SARS-CoV-2 has implications for risk assessment.
D. Skowronski, S. Kaweski, M. Irvine, S. Kim, E. Chuang, S. Sabaiduc, M. Fraser, R. Reyes, B. Henry, P. Levett, M. Petric, M. Krajden, I. Sekirov   +12 more
semanticscholar   +1 more source

Prevalence of hepatitis B virus amongst refugees, asylum seekers and internally displaced persons in low‐ and middle‐income countries: A systematic review

Journal of Viral Hepatitis, Volume 30, Issue 1, Page 4-18, January 2023., 2023
Abstract Hepatitis B, caused by the hepatitis B virus (HBV), is a global public health issue that affects 290 million people worldwide. Most people with hepatitis B are in low‐ and middle‐income countries (LMIC), where health systems and resources are often constrained.
Caroline Lee, Theophilus I. Emeto, Nick Walsh   +2 more
wiley   +1 more source

Seroprevalence of toxoplasmosis in Vojvodina

Srpski arhiv za celokupno lekarstvo, 2010
Introduction Toxoplasmosis is an acute infectious anthropozoonotic disease with mild asymptomatic clinical manifestations in immunocompetent persons and more severe in immunocompromised patients. Acute infection in pregnancy can result in severe congenital toxoplasmosis with severe sequels.
Snezana Brkic, Gorana Gajski, Mirjana Bogavac, Daniela Maric, Vesna Turkulov, Slavica Tomic   +5 more
openaire   +4 more sources

Seroprevalence of Wenzhou virus in China

Biosafety and Health, 2020
Wenzhou virus (WENV) was first identified in rodents and Asian house shrews in Wenzhou, Zhejiang Province, China. However, little is known about the prevalence of WENV infections in humans in China. To determine the threat that WENV may pose to humans, we determine the seroprevalence of WENV in healthy individuals in China in this study.
Jingdong Song, Chao Wu, Conghui Wang, Lianlian Han, Shasha Liu, Jianwei Wang, Hu Zhang, Hongli Zhou, Li Guo   +8 more
openaire   +4 more sources

Strongyloides stercoralis seroprevalence in Vietnam [PDF]

Epidemiology and Infection, 2017
SUMMARYStrongyloidiasis is a neglected tropical disease caused by the roundworm Strongyloides stercoralis affecting 30–100 million people worldwide. Many Southeast-Asian countries report a high prevalence of S. stercoralis infection, but there are little data from Vietnam. Here, we evaluated the seroprevalence of S.
Nguyen Thi Ngọc Diep, Pham Quang Thai, NGHIEM NGUYEN MINH TRANG, Julia Jäger, Annette Fox, Peter Horby, Hoang Vu Mai Phuong, Đặng Đức Anh, Lê Quynh, H. Rogier van Doorn, Behzad Nadjm   +10 more
openaire   +4 more sources

On the use of the reproduction number for SARS‐CoV‐2: Estimation, misinterpretations and relationships with other ecological measures

Journal of the Royal Statistical Society: Series A (Statistics in Society), Volume 185, Issue S1, Page S16-S27, November 2022., 2022
Abstract The basic reproduction number, R0, and its real‐time analogue, Rt, are summary measures that reflect the ability of an infectious disease to spread through a population. Estimation methods for Rt have a long history, have been widely developed and are now enhanced by application to the COVID‐19 pandemic. While retrospective analyses of Rt have
Nicholas P. Jewell, Joseph A. Lewnard
wiley   +1 more source

Hepatitis A seroprevalence in Tuscany, Italy [PDF]

Eurosurveillance, 2009
Information regarding the current seroprevalence of hepatitis A virus (HAV) is useful for the control of HAV infections. The objective of our study was to evaluate the prevalence of anti-HAV antibodies among children (1-5 years old) and young adults (15-20 years old) in Tuscany, in central Italy.
GENTILE, C., ALBERINI, I., MANINI, I., ROSSI, S., MONTOMOLI, E., POZZI, T., RIZZO, C., ALFONSI, V.   +7 more
openaire   +5 more sources

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

Science, 2020
Pandemic progress in Kenya By the end of July 2020, Kenya h ad reported only 341 deaths and ∼20,000 cases of COVID-19. This is in marked contrast to the tens of thousands of deaths reported in many higher-income countries.
S. Uyoga, I. Adetifa, H. Karanja, J. Nyagwange, J. Tuju, P. Wanjiku, R. Aman, M. Mwangangi, P. Amoth, K. Kasera, W. Ng’ang’a, C. Rombo, C. Yegon, K. Kithi, E. Odhiambo, T. Rotich, I. Orgut, S. Kihara, M. Otiende, C. Bottomley, Z. N. Mupe, E. Kagucia, K. Gallagher, A. Etyang, S. Voller, J. Gitonga, D. Mugo, C. Agoti, E. Otieno, L. Ndwiga, T. Lambe, D. Wright, E. Barasa, B. Tsofa, P. Bejon, L. Ochola-Oyier, A. Agweyu, J. Scott, G. Warimwe   +38 more
semanticscholar   +1 more source

Seroprevalence of COVID-19 in Oran: Cross-Sectional Study

Microbiology Spectrum, 2023
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was introduced in Algeria in March 2020. This study aimed to estimate the seroprevalence of SARS-CoV-2 infection in Oran, Algeria, and
Abdessamad Dali-Ali, Dalia Kheira Derkaoui, Mohamed Zina, Asmaa Oukebdane   +3 more
doaj   +1 more source

Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence

Hepatology, 2013
In efforts to inform public health decision makers, the Global Burden of Diseases, Injuries, and Risk Factors 2010 (GBD2010) Study aims to estimate the burden of disease using available parameters.
K. Mohd Hanafiah, J. Groeger, A. Flaxman, S. Wiersma   +3 more
semanticscholar   +1 more source